Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ben-Shachar

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Psychiatry Research|May 2, 2000
Paroxetine binding in aggressive schizophrenic patientsI Modai, A Gibel, B Rauchverger, et al.
Journal of Neurochemistry|March 1, 1994
Typical and atypical neuroleptics induce alteration in blood-brain barrier and brain 59FeCl3 uptakeD Ben-Shachar, E Livne, I Spanier, et al.
Advances in Neurology|January 1, 1993
The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's diseaseM B Youdim, D Ben-Shachar, G Eshel, et al.
Biochemical Pharmacology|May 9, 2000
The effects of bile acids on beta-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranesH Gazawi, P Ljubuncic, U Cogan, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|January 1, 1987
Normal zinc and iron concentrations in mice after early exposure to phenobarbitalC G Pick, M Statter, D Ben Shachar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 26, 2000
Rat brain monoamines after acute and chronic myo-inositol treatmentH Einat, R H Belmaker, M Kopilov, et al.
Journal of Neurochemistry|September 1, 1992
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysisK Jellinger, E Kienzl, G Rumpelmair, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2001
A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytesT Ilani, D Ben-Shachar, R D Strous, et al.
Neurotoxicology and Teratology|August 30, 2002
Influence of neuromelanin on oxidative pathways within the human substantia nigraK L Double, D Ben-Shachar, M B H Youdim, et al.
Journal of Neurochemistry|May 1, 1993
Neuromelanin and nigrostriatal dopamine neuron degenerationK Jellinger, E Kienzl, G Rumpelmair, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Psychiatry Research|May 2, 2000
Paroxetine binding in aggressive schizophrenic patientsI Modai, A Gibel, B Rauchverger, et al.
Journal of Neurochemistry|March 1, 1994
Typical and atypical neuroleptics induce alteration in blood-brain barrier and brain 59FeCl3 uptakeD Ben-Shachar, E Livne, I Spanier, et al.
Advances in Neurology|January 1, 1993
The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's diseaseM B Youdim, D Ben-Shachar, G Eshel, et al.
Biochemical Pharmacology|May 9, 2000
The effects of bile acids on beta-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranesH Gazawi, P Ljubuncic, U Cogan, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|January 1, 1987
Normal zinc and iron concentrations in mice after early exposure to phenobarbitalC G Pick, M Statter, D Ben Shachar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 26, 2000
Rat brain monoamines after acute and chronic myo-inositol treatmentH Einat, R H Belmaker, M Kopilov, et al.
Journal of Neurochemistry|September 1, 1992
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysisK Jellinger, E Kienzl, G Rumpelmair, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2001
A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytesT Ilani, D Ben-Shachar, R D Strous, et al.
Neurotoxicology and Teratology|August 30, 2002
Influence of neuromelanin on oxidative pathways within the human substantia nigraK L Double, D Ben-Shachar, M B H Youdim, et al.
Journal of Neurochemistry|May 1, 1993
Neuromelanin and nigrostriatal dopamine neuron degenerationK Jellinger, E Kienzl, G Rumpelmair, et al.
Pageof 6